Results 221 to 230 of about 9,367,299 (338)

Deep Andromeda JCMT-SCUBA2 Observations. The Submillimeter Maps and Giant Molecular Clouds [PDF]

Jiao, Sihan, Wu, Jingwen, Liu, Hauyu Baobab, Tsai, Chao-Wei, Lin, Yuxin, Li, Di, Zhang, Zhi-Yu, Cheng, Yu, Feng, Linjing, Beuther, Henrik, Wang, Junzhi, Lin, Lihwai, Brok, Jakob den, Zhang, Ludan, Xu, Fengwei, Meng, Fanyi, Li, Zongnan, Keenan, Ryan P., Yu, Si-Yue, Yu, Niankun, Zheng, Zheng, Liu, Junhao, Liu, Yuxiang, Ruan, Hao, Deng, Fangyuan, Xiong, Yuanzhen   +25 more
openalex  

Soil Moisture 2013-2024 (raster 1km), Ground-Based Observations for Validation project sites - version 4.1.0, Dec 2025

Copernicus Land Monitoring Service helpdesk, Copernicus Land Monitoring Service   +1 more
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Reconstruction of Antarctic sea ice thickness from sparse satellite laser altimetry data via deep learning. [PDF]

Sci Data
Ma Z, Yang Q, Xu Y, Shi W, Dong X, Shi Q, Luo H, Liu J, Uotila P, Nie Y.   +9 more
europepmc   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Water use and conservation in the operating room and perioperative setting: A scoping review. [PDF]

PLoS One
Kramer N, Zhu J, Herzig MX, Meiklejohn DA.   +3 more
europepmc   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Seasonality and Declining Intensity of Methane Emissions from the Permian and Nearby US Oil and Gas Basins. [PDF]

Environ Sci Technol
Varon DJ, Jacob DJ, Estrada LA, Balasus N, East JD, Pendergrass DC, Chen Z, Sulprizio M, Omara M, Gautam R, Barkley ZR, Saldaña FJC, Reidy EK, Kamdar H, Sherwin ED, Biraud SC, Jervis D, Pandey S, Worden JR, Bowman KW, Maasakkers JD, Kleinberg RL.   +21 more
europepmc   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source